HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pazopanib for advanced liposarcoma.

AuthorsJudith A Gilbert
JournalThe Lancet. Oncology (Lancet Oncol) Vol. 18 Issue 10 Pg. e564 (10 2017) ISSN: 1474-5488 [Electronic] England
PMID28844815 (Publication Type: News)
Chemical References
  • Antineoplastic Agents
  • Indazoles
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • pazopanib
Topics
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Clinical Trials, Phase II as Topic
  • Disease Progression
  • Disease-Free Survival
  • Humans
  • Indazoles
  • Liposarcoma (drug therapy, enzymology, mortality, pathology)
  • Protein Kinase Inhibitors (adverse effects, therapeutic use)
  • Pyrimidines (adverse effects, therapeutic use)
  • Sulfonamides (adverse effects, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: